title: Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil.
authors.affiliation: Program of Post-Graduation in Medicine and Health, Federal University of Bahia, Salvador, Bahia, Brazil.|Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil.
authors.forename: Sostenes
authors.initials: S
authors.lastname: Mistro
authors.affiliation: Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil.
authors.forename: Marlon
authors.initials: M
authors.lastname: Rodrigues
authors.affiliation: Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil.
authors.forename: Lorena
authors.initials: L
authors.lastname: Rosa
authors.affiliation: Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil.
authors.forename: Marianne
authors.initials: M
authors.lastname: Camargo
authors.affiliation: Program of Post-Graduation in Medicine and Health, Federal University of Bahia, Salvador, Bahia, Brazil.|Department of Medicine and Diagnosis, Federal University of Bahia, Salvador, Bahia, Brazil.
authors.forename: Roberto
authors.initials: R
authors.lastname: Badaró
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001938:Brazil; D006801:Humans; D007391:International Cooperation; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000517:prevention & control; D014330:Tropical Medicine
chemical_list: D000981:Antiprotozoal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B
keywords: Brazil; access to medication; developing countries; leishmaniasis; liposomal amphotericin B; pharmacoeconomics